Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project

Garcia Quesada, Maria; Yang, Yangyupei; Bennett, Julia C.; Hayford, Kyla; Zeger, Scott L.; Feikin, Daniel R.; Peterson, Meagan E.; Cohen, Adam L.; Almeida, Samanta C. G.; Ampofo, Krow; Ang, Michelle; Bar-Zeev, Naor; Bruce, Michael G.; Camilli, Romina; Chanto Chacón, Grettel; Ciruela, Pilar; Cohen, Cheryl; Corcoran, Mary; Dagan, Ron; De Wals, Philippe; ... (2021). Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project. Microorganisms, 9(4) MDPI 10.3390/microorganisms9040738

Preview

Text microorganisms-09-00738.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview

Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project described the serotype distribution of remaining pneumococcal meningitis in countries using PCV10/13 for least 5-7 years with primary series uptake above 70%. The distribution was estimated using a multinomial Dirichlet regression model, stratified by PCV product and age. In PCV10-using sites (N = 8; cases = 1141), PCV10 types caused 5% of cases <5 years of age and 15% among ≥5 years; the top serotypes were 19A, 6C, and 3, together causing 42% of cases <5 years and 37% ≥5 years. In PCV13-using sites (N = 32; cases = 4503), PCV13 types caused 14% in <5 and 26% in ≥5 years; 4% and 13%, respectively, were serotype 3. Among the top serotypes are five (15BC, 8, 12F, 10A, and 22F) included in higher-valency PCVs under evaluation. Other top serotypes (24F, 23B, and 23A) are not in any known investigational product. In countries with mature vaccination programs, the proportion of pneumococcal meningitis caused by vaccine-in-use serotypes is lower (≤26% across all ages) than pre-PCV (≥70% in children). Higher-valency PCVs under evaluation target over half of remaining pneumococcal meningitis cases, but questions remain regarding generalizability to the African meningitis belt where additional data are needed.

Interest & Impact

Downloads

37 since deposited on 10 Nov 2021
25 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item